ZYVERSA THERAPEUTICS INC (ZVSA) Forecast, Price Target & Analyst Ratings

NASDAQ:ZVSA • US98987D3008

Current stock price

0.3113 USD
-0.24 (-43.3%)
At close:
0.289 USD
-0.02 (-7.16%)
After Hours:

Analyst forecast overview

View the latest analyst price targets, stock forecast, EPS estimates, revenue projections, revisions, full estimates, rating distribution and upgrades/downgrades for ZYVERSA THERAPEUTICS INC (ZVSA).

Forecast Snapshot

Consensus Price Target

Price Target
$122.40
+ 39,218.98% Upside
→ Price target details

Next Earnings Forecast

Earnings Estimate
Release Date
Aug 7, 2025
Period
Q2 / 2025
EPS Estimate
-$0.41
Revenue Estimate
→ Full earnings forecast details

ChartMill Buy Consensus

Rating
82.50%
Weighted Analyst Rating Score
→ Analyst Ratings details

Price Target Details & History

Consensus Price Target and Range

Mean target
$122.40
Upside
+ 39,218.98%
From current price of $0.31 to mean target of $122.40, Based on 8 analyst forecasts
Low
$121.20
Median
$122.40
High
$126.00

Price Target Revisions

1 Month
0.00%
3 Months
0.00%

Price Target Summary

8 Wall Street analysts provided a forecast for the next 12 months for ZVSA. The average price target is 122.4 USD. This implies a price increase of 39218.98% is expected in the next year compared to the current price of 0.3113.
→ Find peer stocks trading 30% below analyst price target

Analyst Ratings & History

Current Analyst Ratings

ZVSA Current Analyst RatingZVSA Current Analyst Buy, Sell and Hold Ratings.Current Analyst Rating Strong Buy Buy Hold Sell Strong Sell 1 2 3 4

Analyst Ratings History

ZVSA Historical Analyst RatingsZVSA Historical Analyst Buy, Sell and Hold Ratings and number of analysts.Historical Monthly Analyst Rating -17 -15 -13 -11 -9 -7 -5 -3 -1 2 4 6

Analyst Ratings Consensus

ChartMill Buy Consensus
82.50%
ZVSA was analyzed by 8 analysts. The buy percentage consensus is at 83. So analysts seem to be very confident about ZVSA.
In the previous month the buy percentage consensus was at a similar level.
ZVSA was analyzed by 8 analysts. More opinions would make the average more meaningful.
→ Find peer stocks with a buy consensus above 85%

Recent Upgrades & Downgrades

DateFirmActionFrom → To
2024-03-26HC Wainwright & Co.Reiterate Buy -> Buy
2024-03-12HC Wainwright & Co.Maintains Buy -> Buy
2024-02-29HC Wainwright & Co.Reiterate Buy -> Buy
2023-09-08HC Wainwright & Co.Initiate Buy

Next Earnings Forecast Details

Next Earnings Details

Release Date
Aug 7, 2025
Period
Q2 / 2025
EPS Estimate
-$0.41
Revenue Estimate
Revenue Q2Q
N/A
EPS Q2Q
87.67%
Number of Analysts
3

Next Earnings Revisions

Revenue (1 Month)
N/A
Revenue (3 Months)
N/A
EPS (1 Month)
0.00%
EPS (3 Months)
0.00%

Next Earnings Summary

ZVSA is expected to report earnings on 8/7/2025. The consensus EPS estimate for the next earnings is -0.41 USD and the consensus revenue estimate is 0 USD.
→ Find peers expecting at least 20% revenue growth next quarter

Full Analyst Estimates 2025 - 2029

Yearly Earnings Per Share (EPS), Revenue, EBIT, EBITDA and Operating Margin Analyst Estimates

2020 2021 2022 2023 2024 2025 2026 2027 2028 2029
Revenue
YoY % growth
ZVSA revenue by date.ZVSA revenue by date.
N/AN/AN/AN/AN/A
423.40%
EBITDA
YoY % growth
ZVSA ebitda by date.ZVSA ebitda by date.
-11.823M-7.694M
34.92%		-13.823M
-79.66%		-14.41M
-4.25%		-9.13M
36.64%		N/AN/AN/AN/AN/A
EBIT
YoY % growth
ZVSA ebit by date.ZVSA ebit by date.
-11.833M-7.704M
34.89%		-13.833M
-79.55%		-14.421M
-4.25%		-9.137M
36.64%		N/A
-214.26%		N/A
-40.67%		N/A
-36.24%		N/A
-14.07%		N/A
84.51%
Operating Margin
ZVSA operating margin by date.ZVSA operating margin by date.
N/AN/AN/AN/AN/AN/AN/AN/AN/AN/A
EPS
YoY % growth
ZVSA eps by date.ZVSA eps by date.
N/AN/AN/AN/AN/A
97.53%		N/A
93.00%		N/A
-217.07%		N/A
-1,091.03%		N/A
-22.39%		N/A
17.15%

All data in USD

Quarterly Earnings Per Share (EPS), Revenue, EBIT and EBITDA Analyst Estimates

Q2 / 25 Q3 / 25 Q4 / 25
EPS
Q2Q % growth		-0.41
87.67%		-0.26
89.51%		-0.31
93.36%
Revenue
Q2Q % growth
EBITDA
Q2Q % growth		N/AN/AN/A
EBIT
Q2Q % growth		N/AN/AN/A

All data in USD

Yearly Earnings Per Share (EPS) and Revenue Trends vs Historical Data

ZVSA Yearly Revenue VS EstimatesZVSA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2028 2029 20M 40M 60M 80M
ZVSA Yearly EPS VS EstimatesZVSA Yearly EPS VS EstimatesYearly EPS VS Estimates 2023 2024 2025 2026 2027 2028 2029 -200 -400 -600

Long Term Forward Growth Forecast Summary

Long Term EPS Growth (CAGR)

EPS Next 3 Year
-38.29%
EPS Next 5 Year
-21.81%

Long Term Revenue Growth (CAGR)

Revenue Next 3 Year
N/A
Revenue Next 5 Year
N/A

Long Term EBIT Growth (CAGR)

EBIT Next 3 Year
N/A
EBIT Next 5 Year
N/A
→ Find peers expecting at least 20% CAGR revenue growth over the next 3 years

ZYVERSA THERAPEUTICS INC / ZVSA Forecast FAQ

Can you provide the average price target for ZYVERSA THERAPEUTICS INC stock?

8 analysts have analysed ZVSA and the average price target is 122.4 USD. This implies a price increase of 39218.98% is expected in the next year compared to the current price of 0.3113.

Can you provide the upcoming earnings date for ZYVERSA THERAPEUTICS INC?

ZYVERSA THERAPEUTICS INC (ZVSA) will report earnings on 2025-08-07.

What are the consensus estimates for ZYVERSA THERAPEUTICS INC (ZVSA) next earnings?

The consensus EPS estimate for the next earnings of ZYVERSA THERAPEUTICS INC (ZVSA) is -0.41 USD and the consensus revenue estimate is 0 USD.

What is the consensus rating for ZYVERSA THERAPEUTICS INC (ZVSA) stock?

The consensus rating for ZYVERSA THERAPEUTICS INC (ZVSA) is 82.5 / 100 . This indicates that analysts generally have a positive outlook on the stock.